tiprankstipranks
Company Announcements

Alaunos Therapeutics Regains Nasdaq Listing Compliance

Alaunos Therapeutics Regains Nasdaq Listing Compliance

Alaunos Therapeutics (TCRT) has released an update.

Discover the Best Stocks and Maximize Your Portfolio:

Alaunos Therapeutics, Inc. has successfully regained compliance with Nasdaq’s minimum $1.00 bid price requirement, ensuring its continued listing on The Nasdaq Capital Market. The company has met all necessary criteria and the issue regarding its listing has been resolved. It will, however, be under a mandatory panel monitor for the next year until February 16, 2025, to ensure ongoing compliance.

For further insights into TCRT stock, check out TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1